Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed Feb 14, 2014 · 10-Q · 45 days after period end · 0001062993-14-000839
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Net Income | $358.64K | -$453.52K | -$2.17M | -$1.89M |
| EPS Diluted | -$0.01 | -$0.01 | -$0.08 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Feb 14, 2014 · 45 d after period end
